Volume 91 Issue 20 | p. 18 | Concentrates
Issue Date: May 20, 2013

Ranbaxy To Pay Large Settlement

Department: Business
Keywords: consent decree, GMP, manufacturing, generic drugs

In the largest-ever fine levied against a generic drug manufacturer, Ranbaxy will pay $500 million to settle criminal and civil claims by the U.S. Department of Justice that it knowingly manufactured substandard drugs. In addition to the fine, Ranbaxy pled guilty to felony counts and to . . .

You Do Not Have Access to C&EN Protected Content.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society